NASDAQ: HIND
Vyome Holdings Inc Stock

$7.30-0.24 (-3.18%)
Updated Sep 12, 2025
HIND Price
$7.30
Fair Value Price
N/A
Market Cap
$4.92M
52 Week Low
$7.20
52 Week High
$1,212.99
P/E
-0.02x
P/B
0.84x
P/S
0.44x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.45M
Earnings
-$4.50M
Gross Margin
62.6%
Operating Margin
-68.97%
Profit Margin
-69.7%
Debt to Equity
0.55
Operating Cash Flow
-$8M
Beta
0.85
Next Earnings
Nov 13, 2025
Ex-Dividend
N/A
Next Dividend
N/A

HIND Overview

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HIND's potential to beat the market

DSell
  • Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More

Zen Rating Component Grades

F
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
HIND
Ranked
#80 of 111

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$56.22A
$37.78A
$7.23A
View Top Medical Device Stocks

Be the first to know about important HIND news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HIND scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HIND is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HIND is good value based on its book value relative to its share price (0.84x), compared to the US Medical Devices industry average (4.03x)
P/B vs Industry Valuation
HIND is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more HIND due diligence checks available for Premium users.

Valuation

HIND price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.02x
Industry
31.61x
Market
36.96x

HIND price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.84x
Industry
4.03x
HIND is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HIND's financial health

Profit margin

Revenue
$1.2M
Net Income
-$2.6M
Profit Margin
-211.8%
HIND's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
HIND's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$9.0M
Liabilities
$3.2M
Debt to equity
0.55
HIND's short-term assets ($8.86M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HIND's short-term assets ($8.86M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HIND's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HIND's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.5M
Investing
$0.0
Financing
$6.1M
HIND's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HIND vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HINDD$4.92M-3.18%-0.02x0.84x
NAOVD$5.17M+3.84%-0.05x0.13x
IVFF$4.58M+2.94%-0.01x1.74x
MOVE$5.35M-1.55%-0.19x0.73x
VERO$4.33M+0.43%-0.05x2.30x

Vyome Holdings Stock FAQ

What is Vyome Holdings's quote symbol?

(NASDAQ: HIND) Vyome Holdings trades on the NASDAQ under the ticker symbol HIND. Vyome Holdings stock quotes can also be displayed as NASDAQ: HIND.

If you're new to stock investing, here's how to buy Vyome Holdings stock.

What is the 52 week high and low for Vyome Holdings (NASDAQ: HIND)?

(NASDAQ: HIND) Vyome Holdings's 52-week high was $1,212.99, and its 52-week low was $7.20. It is currently -99.4% from its 52-week high and 1.39% from its 52-week low.

How much is Vyome Holdings stock worth today?

(NASDAQ: HIND) Vyome Holdings currently has 673,334 outstanding shares. With Vyome Holdings stock trading at $7.30 per share, the total value of Vyome Holdings stock (market capitalization) is $4.92M.

Vyome Holdings stock was originally listed at a price of $130,500,130.50 in Oct 6, 2016. If you had invested in Vyome Holdings stock at $130,500,130.50, your return over the last 8 years would have been -100%, for an annualized return of -87.6% (not including any dividends or dividend reinvestments).

How much is Vyome Holdings's stock price per share?

(NASDAQ: HIND) Vyome Holdings stock price per share is $7.30 today (as of Sep 12, 2025).

What is Vyome Holdings's Market Cap?

(NASDAQ: HIND) Vyome Holdings's market cap is $4.92M, as of Sep 13, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Vyome Holdings's market cap is calculated by multiplying HIND's current stock price of $7.30 by HIND's total outstanding shares of 673,334.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.